Microbix Partners with Sekisui Diagnostics for COVID/Flu Test Quality Controls
The collaboration will provide quality assessment products to support the commercialization of a molecular point-of-care assay for COVID-19 and influenza detection.
The collaboration will provide quality assessment products to support the commercialization of a molecular point-of-care assay for COVID-19 and influenza detection.
Researchers developed a smartphone-controlled centrifugal microfluidic device that rapidly detects different subtypes of the influenza virus.
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read MoreScientists report using a nanomaterials-based sensor that can detect the presence of the viruses that cause COVID-19 and the flu.
Read MoreBD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Read MoreNomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Read MoreA new method of rapid, yet quantitative and specific point-of-care detection of antibodies uses an electrochemical cell-free biosensor.
Read MoreVisby Medical has received Emergency Use Authorization (EUA) from the U.S. FDA for its Respiratory Health point of care test.
Read MoreTwo out of three Americans are confused by the differences between polymerase chain reaction, or PCR, tests, and rapid antigen tests.
Read MoreSameday Health launched a single swab test for COVID, influenza A/B strains, and respiratory syncytial virus (RSV).
Read MoreThe Spanish flu, which ravaged the world 100 years ago, is largely forgotten today. Will the same thing happen with the COVID-19 pandemic?
Read MoreCurrently circulating mutant strain variants of influenza are detectable through Cepheid’s respiratory tests.
Read MoreJin Yong Jeon of Hanyang University discussed a technique using a machine learning algorithm to diagnose pneumonia through passive listening.
Read MoreSyndromic testing provides labs flexibility, maximizes equipment and personnel resources, and helps control costs.
Read MoreThe cost of returning to normal activities may not only be a spike in COVID and the more common coronavirus the “common” cold, but influenza. Testing for both coronaviruses and influenza should be standard operating procedure at the first sign of symptoms.
Read MoreResearchers have discovered a high prevalence of COVID co-infections in central Missouri during the 2021-2022 flu season.
Read MoreResearchers used nose swabs from children with RSV in the PICU within a few days of hospital stay to examine what genes respond to the virus.
Read More